Abstract:Sepsis-associatedencephalopathy is a severe systemic infectioncomplication. Although early stages involve pathophysiological changes,detection using conventional imaging is challenging. Glutamate chemicalexchange saturation transfer and diffusion kurtosis imaging can noninvasivelyinvestigate cellular and molecular events in early disease stagesusing magnetic resonance imaging (MRI). N-Acetylcysteine,an antioxidant and precursor of glutathione, regulates neurotransmitterglutamate metabolism and participates in neuroinflammation. We investigatedthe protective role of n-acetylcysteine in sepsis-associatedencephalopathy using a rat model and monitored changes in brain usingmagnetic resonance (MR) molecular imaging. Bacterial lipopolysaccharidewas injected intraperitoneally to induce a sepsis-associated encephalopathymodel. Behavioral performance was assessed using the open-field test.Tumor necrosis factor alpha and glutathione levels were detectedbiochemically. Imaging was performed using a 7.0-T MRI scanner. Proteinexpression, cellular damage, and changes in blood-brain barrierpermeability were assessed using western blotting, pathological staining,and Evans blue staining, respectively. Lipopolysaccharide-inducedrats showed reduced anxiety and depression after treatment with n-acetylcysteine.MR molecular imaging can identify pathological processes at differentdisease stages. Furthermore, rats treated with n-acetylcysteineshowed increased glutathione levels and decreased tumor necrosis factor alpha, suggesting enhanced antioxidant capacity and inhibition ofinflammatory processes, respectively. Western blot analysis showedreduced expression of nuclear factor kappa B (p50) protein after treatment,suggesting that n-acetylcysteine inhibits inflammationvia this signaling pathway. Finally, n-acetylcysteine-treatedrats showed reduced cellular damage by pathology and reduced extravasationof their blood-brain barrier by Evans Blue staining. Thus, n-acetylcysteine might be a therapeutic option for sepsis-associatedencephalopathy and other neuroinflammatory diseases. Furthermore,noninvasive "dynamic visual monitoring" of physiologicaland pathological changes related to sepsis-associated encephalopathywas achieved using MR molecular imaging for the first time, providinga more sensitive imaging basis for early diagnosis, identification,and prognosis.

Role of Imaging Modalities and N-acetylcysteine Treatment in Sepsis-Associated Encephalopathy

Magnetic resonance spectroscopy for assessment of brain injury in the rat model of sepsis.

Early Diagnosis of Murine Sepsis-Associated Encephalopathy Using Dynamic PET/CT Imaging and Multiparametric MRI

Basic research and clinical progress of sepsis-associated encephalopathy

In vivo Detection of Macromolecule Free Radicals in Mouse Sepsis-Associated Encephalopathy Using a New MRI and Immunospin Trapping Strategy

Electroacupuncture Alleviates Neuroinflammation by Inhibiting the HMGB1 Signaling Pathway in Rats with Sepsis-Associated Encephalopathy

ROLE OF MICROGLIA IN SEPSIS-ASSOCIATED ENCEPHALOPATHY PATHOGENESIS: AN UPDATE

Electroacupuncture pretreatment with different waveforms prevents brain injury in rats subjected to cecal ligation and puncture via inhibiting microglial activation, and attenuating inflammation, oxidative stress and apoptosis

Neurodegenerative Evidence in Mice Brains with Cecal Ligation and Puncture-Induced Sepsis: Preventive Effect of the Free Radical Scavenger Edaravone

Activation of glucagon-like peptide-1 receptor in microglia exerts protective effects against sepsis-induced encephalopathy via attenuating endoplasmic reticulum stress-associated inflammation and apoptosis in a mouse model of sepsis

S100B/RAGE/Ceramide Signaling Pathway is Involved in Sepsis-Associated Encephalopathy

Glutamate Chemical Exchange Saturation Transfer (GluCEST) Magnetic Resonance Imaging in Pre-clinical and Clinical Applications for Encephalitis

Cortistatin-14 Exerts Neuroprotective Effect Against Microglial Activation, Blood-brain Barrier Disruption, and Cognitive Impairment in Sepsis-associated Encephalopathy

Dichloroacetate attenuates brain injury through inhibiting neuroinflammation and mitochondrial fission in a rat model of sepsis-associated encephalopathy

Esketamine improves cognitive function in sepsis-associated encephalopathy by inhibiting microglia-mediated neuroinflammation

Post-treatment with N-acetylcysteine ameliorates endotoxin shock-induced organ damage in conscious rats

Sepsis and Cerebral Dysfunction: BBB Damage, Neuroinflammation, Oxidative Stress, Apoptosis and Autophagy as Key Mediators and the Potential Therapeutic Approaches

The Advance of Pathogenesis of Sepsis-Associated Encephalopathy

3-Methyladenine attenuates neuroinflammation and improves cognitive function in sepsis-associated encephalopathy by inhibiting autophagy

Protective Effects of Cannabinoid Type 2 Receptor Activation Against Microglia Overactivation and Neuronal Pyroptosis in Sepsis-Associated Encephalopathy

Pentamidine Protects Mice from Cecal Ligation and Puncture-Induced Brain Damage Via Inhibiting S100B/RAGE/NF-κB